Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients

PURPOSE: Denosumab is a monoclonal antibody that prevents the development of osteoclasts. The effect of denosumab in solid organ transplant recipients has been elucidated, but its effect in haematopoietic stem cell transplantation recipients has not been studied yet. The aim of this study was to det...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Endocrinol
Egile Nagusiak: Jeong, Chaiho, Kim, Hee-Je, Lee, Seok, Kang, Moo Il, Ha, Jeonghoon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218957/
https://ncbi.nlm.nih.gov/pubmed/32454821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3410921
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak